bilaterals.org logo
bilaterals.org logo

medicines


The Transpacific Partnership will impact sovereign control over health policies
A text that Peru and 11 other countries (including the US) are negotiating in secret, seeks to expand drug patents for more than 20 years thus generating millions of overheads for our health system and making it even more difficult to obtain biological medicines against cancer.
Trans-Pacific Partnership: Trade deal could force Australian Government to spend millions to subsidise medicines, expert warns
Australia’s primary negotiator on medicines for the US-Australia FTA, Dr Ruth Lopert, warns that the TPP could force the Australian Government to spend hundreds of millions of dollars to subsidise medicines.
Intellectual property issues hinder TPP talks in Hawaii
Chief negotiators in Trans-Pacific Partnership talks failed to iron out differences over the last week, with intellectual property protection on medicines and environmental protection being key stumbling blocks.
US Ambassador confirms patent linkage under FTA includes biologics
The US Ambassador Lippert has sent a letter to the Korean Minister of Food and Drug Safety requesting protection of biologics under the patent linkage system. He also confirmed that the US seeks the same protection in TPP.
TPP free trade agreement would increase cost of medicine In Mexico, Peru, Chile, and other countries
TPP — the Trans-PacificPartnership — is making waves from Peru to Australia, concerning public health officials and consumer advocates.
Will a new US-led IP empire in India put access to medicines at risk?
Prof Brook K Baker, Professor of Law and Northeastern University, cautions that the Modi government’s accelerating flirtation with the US and its investors is dangerous to hundreds of millions of people worldwide whose lives depend on Indian generics
Affordable medicines could be at risk as US seeks to firm up protections
Access to affordable medicines could be under threat in Australia if the United States gets its way in secretive negotiations over a massive trade deal involving 12 Pacific-region countries, academics have warned.
DNP+ response to RCEP negotiations on Intellectual Property ongoing in Thailand
Japan is pushing for intellectual property rules in the Regional Comprehensive Economic Partnership that will undermine and delay access to affordable generic medecine in Asia.
Calling TPP a ’death pact,’ health advocates rally outside secretive trade talks
Braving snow and blizzard warnings, health, labor and environmental activists rallied outside a New York City hotel on Monday where industry leaders met with international trade representatives to commence the "final negotiations" over the secret text of the Trans-Pacific Partnership.
Doctors Without Borders flies aerial banner to protest Obama trade deal
MSF took its protest against the TPP to the skies, flying an aerial banner that read “Doctors to Obama: Keep #TPP Away From Our Medicines” along the Hudson River.
The TPPA and HIV treatment in Vietnam
Only 30% of Vietnam’s eligible HIV patients would have access to ARVs under the US 2014 TPPA proposals, instead of the 68% receiving treatment today.
People living with HIV rally in streets of Delhi as India hosts RCEP trade negotiations
As the 6th round of negotiations on the Regional Comprehensive Economic Partnership (RCEP) trade agreement take place in India, people living with HIV are rallying in the streets of New Delhi to warn that harmful intellectual property provisions - put forth by Japan - could severely restrict access to affordable medicines for people in developing countries.
AMA wants assurance TPP deal won’t push up medicine prices
The Australian Medical Association (AMA) wants assurances that a Trans Pacific Partnership (TPP) deal will not push up medicine prices.
Trade Minister Andrew Robb lashes out at free trade scaremongering
Australian Trade Minister Andrew Robb lashed out at consumer groups and the Greens for spreading misinformation about the Trans-Pacific Partnership, before walking into a meeting with 11 trade counterparts in Sydney on Saturday to finalise the "basic elements" of the deal.
Intellectual property protection is hurting Ebola victims
Many critics are pointing out that the lack of an Ebola vaccine is due to the intellectual property protections offered through trade deals like the Transatlantic Trade and Investment Partnership.
Peruvian patients reject TPP claiming it will affect their access to medication
Social organizations defending the interests of health patients have spoken out against the TPP.
Responding to frequently asked questions: TPP TTIP pharmaceutical reimbursement “transparency”
Brand name pharmaceutical companies are advocating for inclusion of disciplines on public pharmaceutical reimbursement programs in the ongoing negotiations of the Trans-Pacific Partnership and the Transatlantic Trade and Investment Partnership.
Trading away access to medicines "revisited"
How the European trade agenda continues to undermine access to medicines
EU must allay fears about free trade with Canada, Danish minister say
Danish companies — such as pharmaceutical giant Novo-Nordisk, who will get expanded patent protection in Canada — see huge opportunities for boosting their revenues through CETA.
Médecins Sans Frontières warns about IP inclusion in Asian FTA
The inclusion of intellectual property in the ongoing negotiations of the Regional Comprehensive Economic Partnership between 16 countries, most of them Asian, is raising concerns about “TRIPS-plus” measures that could jeopardise generic drugs production in India, according to Médecins Sans Frontières.